Sangamo Therapeutics (SGMOQ) Interest & Investment Income (2012 - 2025)
Sangamo Therapeutics (SGMOQ) reported Interest & Investment Income of $252,000 for Q4 2025, down 14.9% from $296,000 a year earlier and down 29.0% from the prior quarter.
Powered by 
Analysis
Sangamo Therapeutics (SGMOQ) Interest & Investment Income (2012 - 2025) Analysis & Trends
For FY2025, Sangamo Therapeutics posted Interest & Investment Income of $1.3 million, down 13.9% from FY2024.
- Interest & Investment Income has a five-year compound annual growth rate of -31.7% (FY2020 to FY2025).
- By year, Interest & Investment Income came in at $1.51 million in FY2024 (-86.4%), $11.1 million in FY2023 (+17.7%), $9.43 million in FY2022 (+76.4%) and $5.35 million in FY2021 (-39.1%).
- The Q4 2025 figure ranks as the lowest quarterly Interest & Investment Income since Q1 2017.
- Year over year, Interest & Investment Income gained in 1 of the last eight quarters, with an average decline of 49.2%.
- The high point for year-over-year Interest & Investment Income in five years was Q1 2023 (growth of 145.4%); the low point was Q3 2024 (a decline of 90.0%).
- Per Business Quant data, the three quarters before Q4 2025 came in at $355,000 (Q3 2025), $386,000 (Q2 2025) and $309,000 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Sangamo Therapeutics | 42.03 Mn | -72.08 Mn | - | 252,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 252,000.00 |
| Sep 30, 2025 | 355,000.00 |
| Jun 30, 2025 | 386,000.00 |
| Mar 31, 2025 | 309,000.00 |
| Dec 31, 2024 | 296,000.00 |
| Sep 30, 2024 | 350,000.00 |
| Jun 30, 2024 | 416,000.00 |
| Mar 31, 2024 | 451,000.00 |
| Dec 31, 2023 | 1.49 Mn |
| Sep 30, 2023 | 3.52 Mn |
| Jun 30, 2023 | 2.80 Mn |
| Mar 31, 2023 | 3.29 Mn |
| Dec 31, 2022 | 3.68 Mn |
| Sep 30, 2022 | 1.77 Mn |
| Jun 30, 2022 | 2.64 Mn |
| Mar 31, 2022 | 1.34 Mn |
| Dec 31, 2021 | 2.34 Mn |
| Sep 30, 2021 | 834,000.00 |
| Jun 30, 2021 | 1.55 Mn |
| Mar 31, 2021 | 625,000.00 |
API Access
Sangamo Therapeutics Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=SGMOQ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "SGMOQ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=SGMOQ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();